The U.S. Food and Drug Administration has approved Verkazia (cyclosporine ophthalmic emulsion; Santen Inc) 0.1% eye drops for the treatment of vernal keratoconjunctivitis (VKC) in children and adults, according to a press release.

“This is an important milestone in Santen’s aim to bring innovative solutions that protect vision for those affected by rare ophthalmic conditions, and is the first prescription product approval for Santen in the U.S. market,” said Tatsuya…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Apr 13, 2021

Most ophthalmologists think AI will improve ophthalmology

Most ophthalmologists have positive opinions on the concept and potential impact of artificial intelligence (AI) in ophthalmology, although some worry about its diagnostic accuracy, according to survey results presented at the 2021 Virtual AAPOS Meeting.

Journal Scan